Lv11
60 积分 2023-04-23 加入
Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial
5小时前
待确认
Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer
4天前
已完结
Clonally expanded, targetable, natural killer-like NKG7 T cells seed the aged spinal cord to disrupt myeloid-dependent wound healing
9天前
已完结
Single-cell analysis of aplastic anemia reveals a convergence of NK and NK-like CD8 + T cells with a disease-associated TCR signature
9天前
已完结
Coordinated immune networks in leukemia bone marrow microenvironments distinguish response to cellular therapy
17天前
已完结
Interferon-induced senescent CD8 + T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer
1个月前
已完结
Hobit identifies tissue-resident memory T cell precursors that are regulated by Eomes
2个月前
已完结
DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activity
3个月前
已完结
DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activity
3个月前
已完结
DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activity
3个月前
已完结
皖公网安备34019202002308
